Here we evaluate the variance in AD status explained by common SNPs and along with all recently identified AD genes, including direct genotyping of the APOE ε2 and ε4 alleles, in 5,708 AD cases and 5,214 clinically ascertained controls. This evidence concerns the gene APOE and Alzheimer disease.